Browsing by Author "Ding, C."
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settingsCEA radioimmunotherapy of post-salvage resected colorectal cancer liver metastases is safe and potentially effective in extending survival.(Amer Soc Clinical Oncology, 2004)
; ;Behr, T. M.; ;Schuler, P. ;Markus, Peter M. ;Ding, C. ;Kovacs, J. ;Horak, I. ;Becker, H.Goldenberg, David M. - Some of the metrics are blocked by yourconsent settingsFractionated-dose radioimmunotherapy in non-Hodgkin's lymphoma (NHL) using DOTA-conjugated, Y-90-radiolabeled, humanized anti-CD22 monoclonal antibody (epratuzumab). Interim results.(Amer Soc Hematology, 2003)
;Chatal, J. F. ;Harousseau, J. L.; ; ;Pfreundschuh, Michael ;Kirsch, C. M. ;Naumann, R. ;Kropp, Joachim ;Wegener, William A. ;Ding, C. ;Horak, I. D.Goldenberg, David M.